MediciNova, Inc.

334 articles about MediciNova, Inc.

• MediciNova, Inc. and Avigen, Inc. Confirm Understanding for Key Terms for a Business Combination

  6/25/2009

• MediciNova, Inc. Announces Plan to Modify Its Phase II Placebo-Controlled Clinical Trial Evaluating MN-221 in Patients With Severe, Acute Exacerbations of Asthma

  5/29/2009

• MediciNova, Inc. Reports First Quarter 2009 Results

  5/15/2009

• MediciNova, Inc. Reports Fourth Quarter and Full Year 2008 Results

  4/1/2009

• MediciNova, Inc. Sends Letter to Avigen, Inc. Board of Directors

  3/24/2009

• MediciNova, Inc. Sends Letter to Avigen, Inc. Board of Directors

  3/20/2009

• MediciNova, Inc. Sends Letter to Avigen, Inc. Board of Directors

  3/12/2009

• MediciNova, Inc. Reaffirms Proposal to Acquire Avigen, Inc.

  2/9/2009

• MediciNova, Inc. Reports Interim Phase II Data From MN-221 Emergency Department Study

  1/12/2009

• MediciNova, Inc. Proposes to Acquire Avigen, Inc.

  12/23/2008

• MediciNova, Inc. Reports Third Quarter 2008 Results

  11/11/2008

• MediciNova, Inc. to Present At the Rodman & Renshaw 10th Annual Healthcare Conference

  11/4/2008

• MediciNova, Inc. to Present At the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum

  10/22/2008

• Data From MediciNova, Inc.'s Two-Year Phase II Clinical Trial of MN-166 in Multiple Sclerosis Presented At the World Congress for Treatment and Research in MS (WCTRIMS)

  9/19/2008

• MediciNova, Inc. Reports Positive Preliminary Results from Phase II Clinical Trial of MN-221 in Moderate to Severe Asthma Patients

  9/9/2008

• MediciNova, Inc. to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008

  9/8/2008

• MediciNova, Inc. Reports Second Quarter 2008 Results

  8/12/2008

• MediciNova, Inc. to Present At the 4th Annual Collins Stewart Growth Conference

  7/7/2008

• MediciNova, Inc. to Host Analyst/Investor Meeting in New York City

  7/2/2008

• MediciNova, Inc. Initiates Phase II Clinical Trial of MN-221 in Moderate to Severe Asthma Patients

  6/23/2008